Movano (NASDAQ:MOVE) CTO Sells $23,672.77 in Stock

Movano Inc. (NASDAQ:MOVE) CTO Michael Aaron Leabman sold 3,377 shares of Movano stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $7.01, for a total transaction of $23,672.77. Following the sale, the chief technology officer directly owned 31,560 shares in the company, valued at $221,235.60. The trade was a 9.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Michael Aaron Leabman also recently made the following trade(s):

• On Wednesday, January 14th, Michael Aaron Leabman sold 6,845 shares of Movano stock. The stock was sold at an average price of $6.66, for a total value of $45,587.70.
• On Tuesday, January 13th, Michael Aaron Leabman sold 2,076 shares of Movano stock. The shares were sold at an average price of $6.94, for a total value of $14,407.44.
• On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The shares were sold at an average price of $7.27, for a total transaction of $5,692.41.
• On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The stock was sold at an average price of $7.26, for a total value of $26,085.18.
• On Wednesday, January 7th, Michael Aaron Leabman sold 3,293 shares of Movano stock. The stock was sold at an average price of $7.34, for a total value of $24,170.62.

Movano Trading Down 1.8%

NASDAQ:MOVE traded down $0.13 on Wednesday, reaching $6.92. 36,407 shares of the stock traded hands, compared to its average volume of 31,867. The company has a market capitalization of $5.74 million, a price-to-earnings ratio of -0.64 and a beta of 0.79. Movano Inc. has a 12 month low of $4.67 and a 12 month high of $58.76. The company’s fifty day simple moving average is $8.86 and its 200 day simple moving average is $7.57.

Movano (NASDAQ:MOVE) last posted its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating analysts’ consensus estimates of ($7.00) by $2.27. The firm had revenue of $0.08 million for the quarter, compared to analysts’ expectations of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new stake in shares of Movano Inc. (NASDAQ:MOVE) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent SEC filing. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Analyst Ratings Changes

MOVE has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. Wall Street Zen upgraded Movano to a “hold” rating in a report on Saturday, December 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Movano News Summary

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Institutional buy: Citadel Advisors appears as a new 13F holder (reported stake ~49,262 shares). Large hedge/asset?manager interest can provide support and occasional liquidity to a thinly traded small cap. MarketBeat — Movano summary
• Neutral Sentiment: Broader market pressure: U.S. indices pulled back amid rising geopolitical tensions today, applying downward pressure to small, illiquid tech/health names like Movano. That market backdrop can amplify moves in MOVE. RTTNews — U.S. Stocks Move Sharply Lower
• Neutral Sentiment: Odd short?interest reporting: January short?interest figures in sources show inconsistent/zero values (likely a reporting glitch). Treat short?data as unreliable until exchanges/DTCC updates confirm. (No clear short?squeeze signal.)
• Negative Sentiment: Insider selling — CFO Jeremy Cogan and CTO Michael Leabman disclosed multi?day sales in early January (Cogan: 1/5 and 1/6; larger tranche 8,218 shares on 1/6; CTO sold several tranches on 1/7–1/9). Insider sales at current low liquidity levels are a direct negative for sentiment and can increase selling pressure. SEC filing — Cogan SEC filing — Leabman
• Negative Sentiment: Weak fundamentals / execution risk — Latest quarter (Nov. 14) showed a large EPS loss (but an EPS beat) with effectively negligible revenue (~$0.08M vs. ~ $3.9M estimate) and deeply negative margins/ROE. For a public company with tiny revenue and market cap, any disappointment or need for cash raises dilution risk. MarketBeat — Movano results
• Negative Sentiment: Liquidity & valuation — Market cap is extremely small and daily volume is low; insider sales and weak top line magnify downside risk because even modest sell orders can move the price and fundraising needs could dilute holders further.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.